Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context By Ogkologos - May 22, 2026 124 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the EXTEND study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence MOST POPULAR ESMO-WHO Collaboration in Kazakhstan Yields Evidence-Based Approach for Closing the Gaps... January 31, 2022 Puppy That Was Born Dead Becomes Therapy Dog for Cancer Patient November 27, 2021 What the Reignited Cancer Moonshot Initiative Means for People With Cancer March 29, 2022 Immunotherapy’s Skin Side Effects: Are Microbes to Blame? July 13, 2022 Load more HOT NEWS COVID-19 Pandemic Halts Cancer Care and Damages Oncologists’ Wellbeing [ESMO Press... Bride Diagnosed with Stage IV Triple-Negative Breast Cancer 6 Months Before... Promising Results Observed with Front-line Sintilimab Plus a Bevacizumab Biosimilar in... Working Mom with Stage II Breast Cancer Receives Custom Wig Made...
